These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 19280426)

  • 1. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?
    Lheureux PE; Penaloza A; Zahir S; Gris M
    Crit Care; 2005 Oct; 9(5):431-40. PubMed ID: 16277730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of valproic acid poisoning treated with L-carnitine.
    Chan YC; Tse ML; Lau FL
    Hum Exp Toxicol; 2007 Dec; 26(12):967-9. PubMed ID: 18375641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The decreased level of plasma carnitine in patients with epilepsy].
    Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of L-carnitine supplementation.
    Schiavo A; Maldonado C; Vázquez M; Fagiolino P; Trocóniz IF; Ibarra M
    Eur J Pharm Sci; 2023 Apr; 183():106399. PubMed ID: 36740101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy.
    Mock CM; Schwetschenau KH
    Am J Health Syst Pharm; 2012 Jan; 69(1):35-9. PubMed ID: 22180549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levocarnitine for the Treatment of Valproic Acid-Induced Hyperammonemic Encephalopathy in Children: The Experience of a Large, Tertiary Care Pediatric Hospital and a Poison Center.
    Glatstein M; Bonifacio Rino P; de Pinho S; Scolnik D; Pivko-Levi D; Hoyte C
    Am J Ther; 2019; 26(3):e344-e349. PubMed ID: 29232283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
    Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid overdose and L-carnitine therapy.
    Ishikura H; Matsuo N; Matsubara M; Ishihara T; Takeyama N; Tanaka T
    J Anal Toxicol; 1996; 20(1):55-8. PubMed ID: 8837953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of L-carnitine supplementation on acute valproate intoxication.
    Murakami K; Sugimoto T; Woo M; Nishida N; Muro H
    Epilepsia; 1996 Jul; 37(7):687-9. PubMed ID: 8681902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine as an antidote for acute valproate toxicity in children.
    Russell S
    Curr Opin Pediatr; 2007 Apr; 19(2):206-10. PubMed ID: 17496767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of carnitine supplementation during valproic acid therapy.
    Raskind JY; El-Chaar GM
    Ann Pharmacother; 2000 May; 34(5):630-8. PubMed ID: 10852092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
    Chopra A; Kolla BP; Mansukhani MP; Netzel P; Frye MA
    Gen Hosp Psychiatry; 2012; 34(3):290-8. PubMed ID: 22305367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of hemoperfusion and L-carnitine management in valproic acid overdose.
    Jung J; Eo E; Ahn KO
    Am J Emerg Med; 2008 Mar; 26(3):388.e3-4. PubMed ID: 18358983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-carnitine supplementation in childhood epilepsy: current perspectives.
    De Vivo DC; Bohan TP; Coulter DL; Dreifuss FE; Greenwood RS; Nordli DR; Shields WD; Stafstrom CE; Tein I
    Epilepsia; 1998 Nov; 39(11):1216-25. PubMed ID: 9821988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update.
    Guo HL; Jing X; Sun JY; Hu YH; Xu ZJ; Ni MM; Chen F; Lu XP; Qiu JC; Wang T
    Curr Pharm Des; 2019; 25(3):343-351. PubMed ID: 30931853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-carnitine for acute valproic acid overdose: a systematic review of published cases.
    Perrott J; Murphy NG; Zed PJ
    Ann Pharmacother; 2010; 44(7-8):1287-93. PubMed ID: 20587742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic Acid Overdose: Case Report and Literature Review.
    Patel J; Berezowski I; Mazer-Amirshahi M; Frasure SE; Tran QK; Pourmand A
    J Emerg Med; 2022 Nov; 63(5):651-655. PubMed ID: 36229318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.